{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:05:46Z","timestamp":1774670746787,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/143462\/2019"],"award-info":[{"award-number":["SFRH\/BD\/143462\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa Operacional Capital Humano","award":["SFRH\/BD\/138362\/2018"],"award-info":[{"award-number":["SFRH\/BD\/138362\/2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Frailty and sarcopenia have been extensively studied in heart failure (HF) patients, but their coexistence is unknown. The aim of this work is to describe the coexistence of these conditions in a sample of HF outpatients and its association with the use of medication and left-ventricular ejection fraction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants in this cross-sectional study were recruited from a HF outpatients\u2019 clinic in northern Portugal. Frailty phenotype was assessed according to Fried et al. Sarcopenia was evaluated according to the revised consensus of the European Working Group on Sarcopenia in Older People.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 136 HF outpatients (33.8% women, median age 59\u00a0years) integrated this study. Frailty and sarcopenia accounted for 15.4% and 18.4% of the sample, respectively. Coexistence of frailty and sarcopenia was found in 8.1% of the participants, while 17.6% had only one of the conditions. In multivariable analysis (<jats:italic>n<\/jats:italic>\u2009=\u2009132), increasing age (OR\u2009=\u20091.13;95%CI\u2009=\u20091.06,1.20), being a woman (OR\u2009=\u200965.65;95%CI\u2009=\u200913.50, 319.15), having heart failure with preserved ejection fraction (HFpEF) (OR\u2009=\u20095.61; 95%CI\u2009=\u20091.22, 25.76), and using antidepressants (OR\u2009=\u200911.05; 95%CI\u2009=\u20092.50, 48.82), anticoagulants (OR\u2009=\u20096.11; 95%CI\u2009=\u20091.69, 22.07), furosemide (OR\u2009=\u20093.95; 95%CI\u2009=\u20091.07, 14.55), and acetylsalicylic acid (OR\u2009=\u20095.01; 95%CI\u2009=\u20091.10, 22.90) were associated with increased likelihood of having coexistence of frailty and sarcopenia, while using statins showed the inverse effect (OR\u2009=\u20090.06; 95%CI\u2009=\u20090.01, 0.30).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The relatively low frequency of coexistence of frailty and sarcopenia signifies that each of these two conditions still deserve individual attention from health professionals in their clinical practice and should be screened separately. Being a woman, older age, having HFpEF, using anticoagulants, antidepressants, loop diuretics and acetylsalicylic acid, and not using statins, were associated with having concomitant frailty and sarcopenia. These patients can potentially benefit from interventions that impact their quality of life such as nutritional and mental health interventions and exercise training.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03632-x","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T09:02:21Z","timestamp":1701766941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0124-5427","authenticated-orcid":false,"given":"Rui","family":"Valdiviesso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa F.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Em\u00edlia","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Rita","family":"Sousa-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J. V.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f3nia","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds F.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Silva-Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"issue":"8","key":"3632_CR1","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342\u201356.","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"3632_CR2","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"17","key":"3632_CR3","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2022","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118(17):3272\u201387.","journal-title":"Cardiovasc Res"},{"issue":"236","key":"3632_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijcard.2017.01.153","volume":"1","author":"QE Denfeld","year":"2017","unstructured":"Denfeld QE, Winters-Stone K, Mudd JO, Gelow JM, Kurdi S, Lee CS. The prevalence of frailty in heart failure: A systematic review and meta-analysis. Int J Cardiol. 2017;1(236):283\u20139.","journal-title":"Int J Cardiol"},{"issue":"2","key":"3632_CR5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ehf2.13255","volume":"8","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P, et al. Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Fail. 2021;8(2):1007\u201317.","journal-title":"ESC Heart Fail"},{"issue":"11","key":"3632_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jamda.2018.06.009","volume":"19","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Yuan M, Gong M, Tse G, Li G, Liu T. Frailty and clinical outcomes in heart failure: a systematic review and meta-analysis. J Am Med Dir Assoc. 2018;19(11):1003-1008.e1.","journal-title":"J Am Med Dir Assoc"},{"key":"3632_CR7","doi-asserted-by":"publisher","unstructured":"Konishi M, Kagiyama N, Kamiya K, Saito H, Saito K, Ogasahara Y, et al. Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction. Eur J Prev Cardiol. 2020 Nov 22;(zwaa117). https:\/\/doi.org\/10.1093\/eurjpc\/zwaa117. Cited 2021 Jul 20.","DOI":"10.1093\/eurjpc\/zwaa117"},{"issue":"3","key":"3632_CR8","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-156.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"3632_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331.","journal-title":"Age Ageing"},{"issue":"3","key":"3632_CR10","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/ehf2.13885","volume":"9","author":"T Hamada","year":"2022","unstructured":"Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, et al. Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction. ESC Heart Fail. 2022;9(3):1853\u201363.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"3632_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ihj.2022.12.004","volume":"75","author":"L Chandrashekhar Iyer","year":"2023","unstructured":"Chandrashekhar Iyer L, Vaishali K, Babu AS. Prevalence of sarcopenia in heart failure: a systematic review. Indian Heart J. 2023;75(1):36\u201342.","journal-title":"Indian Heart J"},{"issue":"1","key":"3632_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4330\/wjc.v13.i1.1","volume":"13","author":"M Beltrami","year":"2021","unstructured":"Beltrami M, Fumagalli C, Milli M. Frailty, sarcopenia and cachexia in heart failure patients: different clinical entities of the same painting. World J Cardiol. 2021;13(1):1\u201310.","journal-title":"World J Cardiol"},{"issue":"3","key":"3632_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/heartjnl-2016-309995","volume":"103","author":"Y Kinugasa","year":"2017","unstructured":"Kinugasa Y, Yamamoto K. The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction. Heart. 2017;103(3):184\u20139.","journal-title":"Heart"},{"issue":"1","key":"3632_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00228-020-02951-8","volume":"77","author":"F Pazan","year":"2021","unstructured":"Pazan F, Petrovic M, Cherubini A, Onder G, Cruz-Jentoft AJ, Denkinger M, et al. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials. Eur J Clin Pharmacol. 2021;77(1):1\u201312.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"3632_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s41999-018-0124-5","volume":"10","author":"K Palmer","year":"2019","unstructured":"Palmer K, Villani ER, Vetrano DL, Cherubini A, Cruz-Jentoft AJ, Curtin D, et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med. 2019;10(1):9\u201336.","journal-title":"Eur Geriatr Med"},{"issue":"14","key":"3632_CR16","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.7150\/thno.33000","volume":"9","author":"J Yin","year":"2019","unstructured":"Yin J, Lu X, Qian Z, Xu W, Zhou X. New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure. Theranostics. 2019;9(14):4019\u201329.","journal-title":"Theranostics"},{"issue":"1","key":"3632_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/biomedicines11010136","volume":"11","author":"RH Mellen","year":"2023","unstructured":"Mellen RH, Girotto OS, Marques EB, Laurindo LF, Grippa PC, Mendes CG, et al. Insights into pathogenesis, nutritional and drug approach in sarcopenia: a systematic review. Biomedicines. 2023;11(1):136.","journal-title":"Biomedicines"},{"issue":"6","key":"3632_CR18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.21037\/cdt-21-312","volume":"11","author":"J Cabral","year":"2021","unstructured":"Cabral J, Vasconcelos H, Maia-Ara\u00fajo P, Moreira E, Campelo M, Amorim S, et al. Sacubitril\/valsartan in everyday clinical practice: an observational study based on the experience of a heart failure clinic. Cardiovasc Diagn Ther. 2021;11(6):1217\u201327.","journal-title":"Cardiovasc Diagn Ther"},{"key":"3632_CR19","doi-asserted-by":"crossref","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017 Oct 10;17. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5635569\/. Cited 2020 Dec 9.","DOI":"10.1186\/s12877-017-0621-2"},{"issue":"8","key":"3632_CR20","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1016\/j.numecd.2021.03.028","volume":"31","author":"R Valdiviesso","year":"2021","unstructured":"Valdiviesso R, Azevedo LF, Moreira E, Ata\u00edde R, Martins S, Fernandes L, et al. Frailty phenotype and associated nutritional factors in a sample of Portuguese outpatients with heart failure. Nutr Metab Cardiovasc Dis NMCD. 2021;31(8):2391\u20137.","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"key":"3632_CR21","unstructured":"Schectman O, Sindhu B. Grip Strenght. In: Clinical Assessment Recommendations. American Society of Hand Therapists; 2015."},{"issue":"12","key":"3632_CR22","doi-asserted-by":"publisher","first-page":"e113637","DOI":"10.1371\/journal.pone.0113637","volume":"9","author":"RM Dodds","year":"2014","unstructured":"Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. grip strength across the life course: normative data from twelve British studies. PLoS ONE. 2014;9(12):e113637.","journal-title":"PLoS ONE"},{"issue":"5","key":"3632_CR23","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.clnu.2012.02.007","volume":"31","author":"F Landi","year":"2012","unstructured":"Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr. 2012;31(5):652\u20138.","journal-title":"Clin Nutr"},{"issue":"3","key":"3632_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.clnu.2013.07.013","volume":"33","author":"F Landi","year":"2014","unstructured":"Landi F, Onder G, Russo A, Liperoti R, Tosato M, Martone AM, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr Edinb Scotl. 2014;33(3):539\u201344.","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"6","key":"3632_CR25","doi-asserted-by":"publisher","first-page":"e033661","DOI":"10.1136\/bmjopen-2019-033661","volume":"10","author":"AR Sousa-Santos","year":"2020","unstructured":"Sousa-Santos AR, Afonso C, Borges N, Santos A, Padr\u00e3o P, Moreira P, et al. Sarcopenia, physical frailty, undernutrition and obesity cooccurrence among Portuguese community-dwelling older adults: results from Nutrition UP 65 cross-sectional study. BMJ Open. 2020;10(6):e033661.","journal-title":"BMJ Open"},{"issue":"2","key":"3632_CR26","doi-asserted-by":"publisher","first-page":"em277","DOI":"10.29333\/ejgm\/9695","volume":"18","author":"D Rasheedy","year":"2021","unstructured":"Rasheedy D, EL-Kawaly WH. The cumulative impact of sarcopenia, frailty, malnutrition, and cachexia on other geriatric syndromes in hospitalized elderly. Electron J Gen Med. 2021;18(2):em277.","journal-title":"Electron J Gen Med"},{"issue":"4","key":"3632_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the european working group on sarcopenia in older people. Age Ageing. 2010;39(4):412\u201323.","journal-title":"Age Ageing"},{"issue":"1","key":"3632_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12877-019-1053-y","volume":"19","author":"K Ibrahim","year":"2019","unstructured":"Ibrahim K, Howson FFA, Culliford DJ, Sayer AA, Roberts HC. The feasibility of assessing frailty and sarcopenia in hospitalised older people: a comparison of commonly used tools. BMC Geriatr. 2019;19(1):42.","journal-title":"BMC Geriatr"},{"issue":"1","key":"3632_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12877-019-1115-1","volume":"19","author":"A Gingrich","year":"2019","unstructured":"Gingrich A, Volkert D, Kiesswetter E, Thomanek M, Bach S, Sieber CC, et al. Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients. BMC Geriatr. 2019;19(1):120.","journal-title":"BMC Geriatr"},{"key":"3632_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.arr.2017.03.005","volume":"36","author":"P Soysal","year":"2017","unstructured":"Soysal P, Veronese N, Thompson T, Kahl KG, Fernandes BS, Prina AM, et al. Relationship between depression and frailty in older adults: a systematic review and meta-analysis. Ageing Res Rev. 2017;36:78\u201387.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"3632_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"L Radloff","year":"1977","unstructured":"Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(2):385\u2013401.","journal-title":"Appl Psychol Meas"},{"issue":"13","key":"3632_CR32","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2147\/CIA.S173146","volume":"5","author":"H Wang","year":"2018","unstructured":"Wang H, Hai S, Liu Y, Cao L, Liu Y, Liu P, et al. Association between depressive symptoms and sarcopenia in older Chinese community-dwelling individuals. Clin Interv Aging. 2018;5(13):1605\u201311.","journal-title":"Clin Interv Aging"},{"issue":"2020","key":"3632_CR33","first-page":"e8041489","volume":"23","author":"K Yuenyongchaiwat","year":"2020","unstructured":"Yuenyongchaiwat K, Boonsinsukh R. Sarcopenia and its relationships with depression, cognition, and physical activity in thai community-dwelling older adults. Curr Gerontol Geriatr Res. 2020;23(2020):e8041489.","journal-title":"Curr Gerontol Geriatr Res"},{"issue":"9","key":"3632_CR34","doi-asserted-by":"publisher","first-page":"e038089","DOI":"10.1136\/bmjopen-2020-038089","volume":"10","author":"L Chen","year":"2020","unstructured":"Chen L, Sheng Y, Qi H, Tang T, Yu J, Lv S. Correlation of sarcopenia and depressive mood in older community dwellers: a cross-sectional observational study in China. BMJ Open. 2020;10(9):e038089.","journal-title":"BMJ Open"},{"issue":"2","key":"3632_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/ageing\/afy180","volume":"48","author":"C Wilkinson","year":"2019","unstructured":"Wilkinson C, Todd O, Clegg A, Gale CP, Hall M. Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis. Age Ageing. 2019;48(2):196\u2013203.","journal-title":"Age Ageing"},{"issue":"4","key":"3632_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2169\/internalmedicine.6077-20","volume":"60","author":"H Hori","year":"2021","unstructured":"Hori H, Fukuchi T, Sugawara H. Anticoagulant therapy for frail patients with atrial fibrillation. Intern Med. 2021;60(4):495\u2013506.","journal-title":"Intern Med"},{"issue":"6","key":"3632_CR37","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.4022\/jafib.1870","volume":"10","author":"Z Oqab","year":"2018","unstructured":"Oqab Z, Pournazari P, Sheldon RS. What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? A systematic review and meta-analysis. J Atr Fibrillation. 2018;10(6):1870.","journal-title":"J Atr Fibrillation"},{"issue":"1","key":"3632_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12872-022-02804-5","volume":"22","author":"R Valdiviesso","year":"2022","unstructured":"Valdiviesso R, Sousa-Santos AR, Azevedo LF, Moreira E, Amaral TF, Silva-Cardoso J, et al. Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study. BMC Cardiovasc Disord. 2022;22(1):356.","journal-title":"BMC Cardiovasc Disord"},{"key":"3632_CR39","doi-asserted-by":"publisher","first-page":"101530","DOI":"10.1016\/j.arr.2021.101530","volume":"73","author":"A Picca","year":"2022","unstructured":"Picca A, Coelho-Junior HJ, Calvani R, Marzetti E, Vetrano DL. Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis. Ageing Res Rev. 2022;73:101530.","journal-title":"Ageing Res Rev"},{"issue":"9","key":"3632_CR40","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.15197","volume":"24","author":"J Yin","year":"2020","unstructured":"Yin J, Qian Z, Chen Y, Li Y, Zhou X. MicroRNA regulatory networks in the pathogenesis of sarcopenia. J Cell Mol Med. 2020;24(9):4900\u201312.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"3632_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/MOH.0000000000000424","volume":"25","author":"C Fern\u00e1ndez-Hernando","year":"2018","unstructured":"Fern\u00e1ndez-Hernando C, Su\u00e1rez Y. MicroRNAs in endothelial cell homeostasis and vascular disease. Curr Opin Hematol. 2018;25(3):227\u201336.","journal-title":"Curr Opin Hematol"},{"issue":"117","key":"3632_CR42","first-page":"55","volume":"30","author":"T Zambrano","year":"2018","unstructured":"Zambrano T, Hirata RDC, Hirata MH, Cerda \u00c1, Salazar LA. Statins differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: a pilot study. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2018;30(117):55\u201361.","journal-title":"Eur J Pharm Sci Off J Eur Fed Pharm Sci"},{"issue":"6","key":"3632_CR43","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/cells11060983","volume":"11","author":"U Kansakar","year":"2022","unstructured":"Kansakar U, Varzideh F, Mone P, Jankauskas SS, Santulli G. Functional role of microRNAs in regulating cardiomyocyte death. Cells. 2022;11(6):983.","journal-title":"Cells"},{"issue":"8","key":"3632_CR44","doi-asserted-by":"publisher","first-page":"e15669","DOI":"10.14814\/phy2.15669","volume":"11","author":"WA Fountain","year":"2023","unstructured":"Fountain WA, Naruse M, Finch WH, Claiborne A, Trappe SW, Trappe TA. Influence of aspirin on aging skeletal muscle: Insights from a cross-sectional cohort of septuagenarians. Physiol Rep. 2023;11(8):e15669.","journal-title":"Physiol Rep"},{"issue":"10","key":"3632_CR45","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/gerona\/glab340","volume":"77","author":"SE Espinoza","year":"2022","unstructured":"Espinoza SE, Woods RL, Ekram ARMS, Ernst ME, Polekhina G, Wolfe R, et al. The effect of low-dose aspirin on frailty phenotype and frailty index in community-dwelling older adults in the ASPirin in reducing events in the elderly study. J Gerontol Ser A. 2022;77(10):2007\u201314.","journal-title":"J Gerontol Ser A"},{"issue":"1","key":"3632_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jjcc.2020.01.003","volume":"76","author":"I Nakano","year":"2020","unstructured":"Nakano I, Tsuda M, Kinugawa S, Fukushima A, Kakutani N, Takada S, et al. Loop diuretic use is associated with skeletal muscle wasting in patients with heart failure. J Cardiol. 2020;76(1):109\u201314.","journal-title":"J Cardiol"},{"issue":"11","key":"3632_CR47","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s40266-023-01061-1","volume":"40","author":"C Okoye","year":"2023","unstructured":"Okoye C, Mazzarone T, Cargiolli C, Guarino D. Discontinuation of loop diuretics in older patients with chronic stable heart failure: a narrative review. Drugs Aging. 2023;40(11):981\u201390.","journal-title":"Drugs Aging"},{"issue":"3","key":"3632_CR48","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/ehf2.14114","volume":"10","author":"T Abe","year":"2023","unstructured":"Abe T, Jujo K, Maeda D, Saito K, Ogasahara Y, Saito K, et al. The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients. ESC Heart Fail. 2023;10(3):1698\u2013705.","journal-title":"ESC Heart Fail"},{"issue":"4","key":"3632_CR49","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ahj.2013.07.008","volume":"166","author":"SM McNallan","year":"2013","unstructured":"McNallan SM, Chamberlain AM, Gerber Y, Singh M, Kane RL, Weston SA, et al. Measuring frailty in heart failure: a community perspective. Am Heart J. 2013;166(4):768\u201374.","journal-title":"Am Heart J"},{"issue":"11","key":"3632_CR50","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","volume":"59","author":"S Ather","year":"2012","unstructured":"Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012;59(11):998\u20131005.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3632_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251\u20139.","journal-title":"N Engl J Med"},{"issue":"8","key":"3632_CR52","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/CIRCRESAHA.116.310119","volume":"120","author":"J Roh","year":"2017","unstructured":"Roh J, Houstis N, Rosenzweig A. Why don\u2019t we have proven treatments for HFpEF? Circ Res. 2017;120(8):1243\u20135.","journal-title":"Circ Res"},{"issue":"27","key":"3632_CR53","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"37","key":"3632_CR54","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2023 focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627\u201339.","journal-title":"Eur Heart J"},{"issue":"8","key":"3632_CR55","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3390\/cells10082115","volume":"10","author":"P Mone","year":"2021","unstructured":"Mone P, Gambardella J, Pansini A, de Donato A, Martinelli G, Boccalone E, et al. Cognitive impairment in frail hypertensive elderly patients: role of hyperglycemia. Cells. 2021;10(8):2115.","journal-title":"Cells"},{"issue":"13","key":"3632_CR56","doi-asserted-by":"publisher","first-page":"831556","DOI":"10.3389\/fendo.2022.831556","volume":"14","author":"A Pansini","year":"2022","unstructured":"Pansini A, Lombardi A, Morgante M, Frullone S, Marro A, Rizzo M, et al. Hyperglycemia and physical impairment in frail hypertensive older adults. Front Endocrinol. 2022;14(13):831556.","journal-title":"Front Endocrinol"},{"issue":"1","key":"3632_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40520-021-01897-w","volume":"34","author":"P Mone","year":"2022","unstructured":"Mone P, Gambardella J, Pansini A, Martinelli G, Minicucci F, Mauro C, et al. Cognitive dysfunction correlates with physical impairment in frail patients with acute myocardial infarction. Aging Clin Exp Res. 2022;34(1):49\u201353.","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"3632_CR58","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2337\/dc21-2434","volume":"45","author":"P Mone","year":"2022","unstructured":"Mone P, Lombardi A, Gambardella J, Pansini A, Macina G, Morgante M, et al. Empagliflozin improves cognitive impairment in frail older adults with type 2 diabetes and heart failure with preserved ejection fraction. Diabetes Care. 2022;45(5):1247\u201351.","journal-title":"Diabetes Care"},{"issue":"1","key":"3632_CR59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1124\/jpet.121.001251","volume":"384","author":"P Mone","year":"2023","unstructured":"Mone P, Lombardi A, Kansakar U, Varzideh F, Jankauskas SS, Pansini A, et al. Empagliflozin improves the microrna signature of endothelial dysfunction in patients with heart failure with preserved ejection fraction and diabetes. J Pharmacol Exp Ther. 2023;384(1):116\u201322.","journal-title":"J Pharmacol Exp Ther"},{"issue":"14","key":"3632_CR60","doi-asserted-by":"publisher","first-page":"1203666","DOI":"10.3389\/fendo.2023.1203666","volume":"3","author":"S Zhang","year":"2023","unstructured":"Zhang S, Qi Z, Wang Y, Song D, Zhu D. Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol. 2023;3(14):1203666.","journal-title":"Front Endocrinol"},{"issue":"222","key":"3632_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijcard.2016.07.135","volume":"1","author":"T Bekfani","year":"2016","unstructured":"Bekfani T, Pellicori P, Morris DA, Ebner N, Valentova M, Steinbeck L, et al. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life. Int J Cardiol. 2016;1(222):41\u20136.","journal-title":"Int J Cardiol"},{"issue":"1","key":"3632_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/2047487314564729","volume":"23","author":"H Fukuta","year":"2016","unstructured":"Fukuta H, Goto T, Wakami K, Ohte N. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials. Eur J Prev Cardiol. 2016;23(1):78\u201385.","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"3632_CR63","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/1559827617695219","volume":"13","author":"L Cilia","year":"2017","unstructured":"Cilia L, Saeed A, Ganga HV, Wu WC. Heart failure with preserved ejection fraction: prevention and management. Am J Lifestyle Med. 2017;13(2):182\u20139.","journal-title":"Am J Lifestyle Med"},{"issue":"1","key":"3632_CR64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ehf2.13742","volume":"9","author":"AR de Boer","year":"2022","unstructured":"de Boer AR, Vaartjes I, Gohar A, Valk MJM, Brugts JJ, Boonman-de Winter LJM, et al. Heart failure with preserved, mid-range, and reduced ejection fraction across health care settings: an observational study. ESC Heart Fail. 2022;9(1):363\u201372.","journal-title":"ESC Heart Fail"},{"issue":"97","key":"3632_CR65","doi-asserted-by":"publisher","first-page":"104517","DOI":"10.1016\/j.archger.2021.104517","volume":"1","author":"AR Sousa-Santos","year":"2021","unstructured":"Sousa-Santos AR, Barros D, Montanha TL, Carvalho J, Amaral TF. Which is the best alternative to estimate muscle mass for sarcopenia diagnosis when DXA is unavailable? Arch Gerontol Geriatr. 2021;1(97):104517.","journal-title":"Arch Gerontol Geriatr"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03632-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03632-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T10:02:15Z","timestamp":1701770535000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03632-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3632"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03632-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"assertion":[{"value":"26 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was implemented according to the principles of the Declaration of Helsinki. The Ethics Committee of the <i>Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o<\/i>, the hospital in which this study took place, approved the protocol (reference 57\/17 of the Ethics Committee of the <i>Centro Hospitalar Universit\u00e1rio de S\u00e3o Jo\u00e3o<\/i>). All participants granted their informed consent for the use of data for research purpose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"594"}}